Search Tag: transcatheter aortic valve replacement
2023 11 Oct
A study led by Michigan Medicine has revealed that most individuals who undergo a minimally invasive heart valve replacement procedure do not engage in recommended cardiac rehabilitation. The research, is based on clinical registry and healthcare claims data from more than 3,300 patients who underwent transcatheter aortic valve replacement (TAVR) at...Read more
2019 20 Mar
In the Placement of Aortic Transcatheter Valves (PARTNER) 3 trial, 1,000 patients with severe aortic stenosis and low surgical risk were randomly assigned to undergo either transcatheter aortic-valve replacement (TAVR) or surgical aortic-valve replacement. In these patients, TAVR with transfemoral placement of a balloon-expandable valve was superior...Read more
2018 19 Dec
A new study that explored the relationship between procedural volume and in-hospital adverse events shows that individual operator experience with transcatheter aortic valve replacement (TAVR) plays an important role in achieving better clinical outcomes. The study is published in JACC: Cardiovascular Interventions . The relationship between...Read more
2018 19 Sep
New research from the University of North Carolina School of Medicine indicates that transcatheter aortic valve replacement (TAVR) was associated with shorter hospital stay and more frequent discharge to home, compared to surgical aortic valve replacement (SAVR). Also, the rate of in-hospital deaths among TAVR patients declined from 4.2 percent...Read more
2018 22 May
Researchers in France have developed a new scoring system, based on thoracic aortic calcification (TAC), to predict one-year cardiovascular and all-cause mortality after transcatheter aortic valve replacement (TAVR). The predictive performance of Calcification Prognostic Impact (CAPRI) score was confirmed in an independent contemporary cohort,...Read more
2018 02 May
Transcatheter aortic valve replacement (TAVR) is a procedure used for intermediate, high-risk, and inoperable patients with severe narrowing of the aortic valve where a prosthetic valve is implanted and the damaged valve is replaced. A common risk of TAVR is an ill-fitting valve which can lead to paravalvular leak (PVL). New research shows 3D printing...Read more
2017 22 Aug
A new study indicates that 30-day mortality rates as well as the rates of procedure related complications were similar in transcatheter aortic valve replacement (TAVR) procedures performed with or without the presence of an anaesthesiologist in the catheterisation laboratory. The findings are reported in the International Journal of Cardiology....Read more
2017 11 Jul
This year 2017 marks the 15th anniversary of the first transcatheter aortic valve replacement (TAVR) performed in Rouen in April 2002. The innovative procedure, which profoundly altered the landscape of cardiovascular medicine, can be considered as among the major clinical breakthroughs of the past decade, says an Editorial in the Journal of the American...Read more
2016 20 Dec
A new study looking at the longer-term outcomes after transcatheter aortic valve replacement (TAVR) shows that survival rate is higher in women than men one year after the procedure. Even though women have more complications as a result of the TAVR procedure – especially bleeding and vascular issues – they still fared better than men one year after...Read more
2016 08 Mar
A new statistical model has been developed by researchers at the University of Florida College of Medicine-Jacksonville that can predict risk of in-hospital death after transcatheter aortic valve replacement (TAVR). The study is published in JAMA Cardiology . TAVR is used primarily in patients who have critical aortic stenosis and are not good...Read more
2015 04 Dec
According to a report published by The Annals of Thoracic Surgery and the Journal of the American College of Cardiology, transcatheter aortic valve replacement (TAVR) continues to evolve and has demonstrated positive outcomes for patients with aortic stenosis. When it was first approved, TAVR required cardiothoracic surgeons and cardiologists...Read more
2015 13 Aug
Interventional cardiologists and cardiovascular surgeons at the Orlando Health Heart Institute are the first to use a new self-expanding CoreValve® Evolut™ R System approved for transcatheter aortic valve replacement (TAVR) in severe aortic stenosis patients who are at high or extreme risk for surgery. This new leading edge technology can help improve...Read more